World's Best Scientists 2026 revealed!
Akira Yamada

Akira Yamada

D-Index & Metrics

Immunology

D-Index
57
Citations
8382
World Ranking
3656
National Ranking
143

Akira Yamada publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Akira Yamada sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 248 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Akira Yamada D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Akira Yamada sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Akira Yamada is affiliated with Kurume University in Japan. Their research focuses extensively on medicine, with significant contributions to biochemistry, genetics, molecular biology, immunology, and microbiology. Within these broader fields, Yamada's work concentrates on oncology, immunology, molecular biology, pulmonary and respiratory medicine, and cancer research.

The scientist's scholarly output includes numerous papers published in several peer-reviewed journals. Notable recent publications include:

  • Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries, 2021, Nature Communications
  • ENIGMA CHEK2 gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk, 2023, Clinical Cancer Research
  • Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial, 2020, Cancer Immunology Immunotherapy
  • Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer, 2020, Cancer Science
  • CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine-treated ovarian cancer patients, 2020, Cancer Science

Yamada collaborates regularly with several co-authors, who have published multiple papers together. Frequent collaborators include:

  • Kayoko Waki
  • Kyogo Itoh
  • Nobukazu Komatsu
  • Shigeki Shichijo
  • Kouichiro Kawano

The bulk of Yamada's publications appear in journals such as:

  • Cancer Science
  • Cancer Immunology Immunotherapy
  • Molecular and Clinical Oncology
  • Nature Communications
  • Clinical Cancer Research

The main subjects covered by Yamada's research include cancer immunotherapy and biomarkers, immunotherapy and immune responses, vaccines and immunoinformatics approaches, immune cells in cancer, cancer genomics and diagnostics, aortic disease and treatment approaches, and monoclonal and polyclonal antibodies research.

Overall, Akira Yamada's academic work focuses on molecular mechanisms and clinical applications within oncology and immunology, emphasizing cancer vaccines, immune responses, and genetic factors relevant to cancer risk and treatment outcomes.

Best Publications

  • Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

    T. Higuchi;N. Seki;S. Kamizono;A. Yamada

  • Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

    Yukiko Ohyama;Seiji Nakamura;Goro Matsuzaki;Masanori Shinohara

  • Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL.

    Masanobu Nakao;Shigeki Shichijo;Toshihiro Imaizumi;Yoshiko Inoue

  • Next‐generation peptide vaccines for advanced cancer

    Akira Yamada;Tetsuro Sasada;Masanori Noguchi;Kyogo Itoh

  • Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma

    Naoki Yajima;Ryuya Yamanaka;Takashi Mine;Naoto Tsuchiya

  • Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.

    Masanori Noguchi;Kazuhiko Kobayashi;Norie Suetsugu;Katsurou Tomiyasu

  • Induction of Cellular Immune Responses to Tumor Cells and Peptides in Colorectal Cancer Patients by Vaccination with SART3 Peptides

    Yoshiaki Miyagi;Nobue Imai;Teruo Sasatomi;Akira Yamada

  • Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.

    Takashi Mine;Yuji Sato;Masanori Noguchi;Teruo Sasatomi

  • Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

    Hitoshi Kamiya;Toshiaki Ihara;Akihiko Hattori;Toshiaki Iwasa

  • A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.

    Masanori Noguchi;Tatsuyuki Kakuma;Hirotsugu Uemura;Yasutomo Nasu

  • Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy

    Koichi Azuma;Yoshihiro Komohara;Tetsuro Sasada;Yasuhiro Terazaki

  • Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme

    Mizuhiko Terasaki;Soichiro Shibui;Yoshitaka Narita;Takamitsu Fujimaki

  • Personalized peptide vaccines: a new therapeutic modality for cancer.

    Kyogo Itoh;Akira Yamada

  • Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel

    Koichi Azuma;Tetsuro Sasada;Akihiko Kawahara;Sinzo Takamori

  • Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases.

    Nanae Harashima;Koji Tanaka;Teruo Sasatomi;Kanako Shimizu

  • PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer

    Kayoko Waki;Teppei Yamada;Koichi Yoshiyama;Yasuhiro Terazaki

  • A novel glycoprotein obtained from Chlorella vulgaris strain CK22 shows antimetastatic immunopotentiation.

    Kuniaki Tanaka;Akira Yamada;Kiyoshi Noda;Takashi Hasegawa

  • A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer

    Kazuhiro Yoshimura;Takafumi Minami;Masahiro Nozawa;Takahiro Kimura

  • Molecular Cloning of a Glycosylphosphatidylinositol-Anchored Molecule CDw108

    Akira Yamada;Keisuke Kubo;Toshikazu Takeshita;Nanae Harashima

  • Vaccination with predesignated or evidence-based peptides for patients with recurrent gynecologic cancers.

    Naotake Tsuda;Kazuo Mochizuki;Mamoru Harada;Aki Sukehiro

  • Tissue-specific distribution and age-dependent increase of human CD11b+ T cells.

    T Hoshino;A Yamada;J Honda;Y Imai

  • Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients.

    Takashi Mine;Rumi Gouhara;Naoya Hida;Nobue Imai

Frequent Co-Authors

Kyogo Itoh
Kyogo Itoh Kurume University
Michio Sata
Michio Sata Kurume University
Kikuo Nomoto
Kikuo Nomoto Kyushu University
Seiji Naito
Seiji Naito Kyushu University
Satoru Todo
Satoru Todo Hokkaido University
Yasunobu Yoshikai
Yasunobu Yoshikai Kyushu University
Yukihiro Shoyama
Yukihiro Shoyama Nagasaki International University
Nobuoki Kohno
Nobuoki Kohno Hiroshima University
Atsushi Natsume
Atsushi Natsume Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related advanced nursing degrees can open diverse career opportunities in healthcare research and patient care. Many professionals transition from roles such as Family Nurse Practitioners to more specialized fields through programs like the fnp to acnp bridge program online, which offers a streamlined path to acute care specialization.

Students eager to enter clinical practice quickly might explore accelerated fnp programs. These programs balance rigorous coursework with online flexibility, ideal for those seeking fast-paced advancement while managing other commitments.

For individuals without a nursing background but interested in nursing careers that intersect with immunological sciences, online accelerated nursing programs for non nurses provide accessible entry points into the profession, allowing a quicker transition into healthcare roles.

Additionally, the easiest absn to get into options cater to those seeking reasonably attainable admissions criteria without compromising quality, making them ideal for busy learners focusing on foundational nursing education as a stepping stone towards immunology-related careers.

Best Scientists Citing Akira Yamada

Trending Scientists

Recently Published Articles